Mitsubishi UFJ Asset Management (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$993K	Sell	2,000 -2,000	-50%	-$886K	0.46%	67
2026 Q1	$1.79M	Buy	+4,000	New	+$1.87M	0.92%	37
2025 Q4	–	Sell	-2,200	Closed	-$862K	–	112
2025 Q3	$862K	Buy	+2,200	New	+$919K	0.42%	68
2025 Q2	–	Sell	-1,000	Closed	-$485K	–	118
2025 Q1	$485K	Sell	1,000 -1,500	-60%	-$699K	0.26%	84
2024 Q4	$1.01M	Buy	+2,500	New	+$1.16M	0.44%	58

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s VRTX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management (UK) reduced its Vertex Pharmaceuticals (VRTX) stake by 50% in Q2 2026, selling an estimated $886K and leaving 2,000 shares worth $993K. The position accounts for 0.46% of the portfolio, ranked #67.

Mitsubishi UFJ Asset Management (UK) first reported a position in VRTX in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.79M in Q1 2026. 576 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Mitsubishi UFJ Asset Management (UK) held 2,000 shares of Vertex Pharmaceuticals worth $993K as of Q2 2026.
Mitsubishi UFJ Asset Management (UK) sold 2,000 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886K.
Vertex Pharmaceuticals made up 0.46% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q2 2026, its #67 holding.
Mitsubishi UFJ Asset Management (UK) first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
Mitsubishi UFJ Asset Management (UK)'s Vertex Pharmaceuticals position peaked at $1.79M in Q1 2026.
576 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2026, filed 28 Jul 2026.